Real World Evidence (RWE), Real World Data (RWD) and the Application of Artificial Intelligence (AI) in The Pharmaceutical Marke
Data drives business and all decision making. We need to be aware of its capacity to inform, lead and deliver insights which can be amplified via artificial intelligence (AI). Data is the fuel; AI is the vehicle. The quest for additional quantitative and qualitative data is boundless and will not relent. All sources should be explored including primary, secondary, pharmacy, community and cursory. This is a dynamic field which will need to be carefully navigated. With increased data, invariably conversations look at the impact of AI. In this course, you will explore the business case for adopting the risk versus reward profile to place your organisation at the heart of the latest thinking.
During the course, you will be able to delve deep into the importance of real world evidence (RWE), real world data (RWD) and explore where new data can add value to your organisation.
Upcoming start dates
Suitability - Who should attend?
Benefits of attending
- Learn who the key contacts and players are
- Understand which direction the industry is moving in
- Explore timelines
- Know the patient groups and organisations
- Gain an insight into the UK, EU and USA perspective
Request information - obligation free
Customer Outreach Award
We believe that it should be easy for you to find and compare training courses.
Our Customer Outreach Award is presented to trusted providers who are excellent at responding to enquiries, making your search quicker, more efficient and easier, too.
About IPI Academy
International Professional & Industry Academy (IPI) is an international leading professional training organisation based in London. Our training solutions provide a return on your investment with measurable results, and are delivered by experienced professionals and managed with exceptional care and...